Skip to main content

Akili, Inc.

AKLIDelisted Jul 2, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001850266

Akili, Inc. was delisted on Jul 2, 2024; its insiders filed their last Form 4 on Jul 8, 2024; 35 institutions reported holding it in 13F filings for Q2 2024, worth $20.4M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Akili, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of AKLI: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders36360
Shares41.5M40.8M−769.6K (−1.9%)
Value$46.1M$22.4M−$23.7M (−51.5%)

New holders (7)

Institutions that held Akili, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to AKLI in Q3 2023
InstitutionSharesValue% of portfolio
Bank of America Corp25,118$13.8K0.00%
Two Sigma Securities, LLC13,477$7.40K0.00%
First Manhattan Co8,300$4.55K0.00%
Royal Bank of Canada1,300$1.00K0.00%
JPMorgan Chase & Co28$150.00%
Capital Advisors, Ltd. LLC551$00.00%
Goldman Sachs Group Inc12,045––

Sold out (7)

Institutions that held Akili, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of AKLI in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Charles Schwab Investment Management Inc166,704$185.0K
Perpetual Ltd105,779$117.4K
Cetera Investment Advisers85,000$94.3K
Millennium Management LLC42,736$47.4K
CIBC Asset Management Inc34,807$38.6K
FMR LLC1,500$1.67K
Roffman Miller Associates Inc150$167